Stock Analysis

HEROZ Full Year 2024 Earnings: EPS Misses Expectations

TSE:4382
Source: Shutterstock

HEROZ (TSE:4382) Full Year 2024 Results

Key Financial Results

  • Revenue: JP¥4.84b (up 62% from FY 2023).
  • Net loss: JP¥1.13b (loss widened by 98% from FY 2023).
  • JP¥75.41 loss per share (further deteriorated from JP¥38.20 loss in FY 2023).
earnings-and-revenue-growth
TSE:4382 Earnings and Revenue Growth June 17th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

HEROZ EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 20%.

Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 5.4% growth forecast for the Entertainment industry in Japan.

Performance of the Japanese Entertainment industry.

The company's shares are up 4.7% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with HEROZ, and understanding it should be part of your investment process.

Valuation is complex, but we're helping make it simple.

Find out whether HEROZ is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're helping make it simple.

Find out whether HEROZ is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com